Adelphi Research
Adelphi Research is a UK-headquartered, privately-held healthcare market research consultancy serving global pharmaceutical companies with proprietary methodologies, behavioural science, AI, and agile research platforms across therapy areas including oncology, immunology, and diabetes.
- Company typePrivate
- Founded1992
- HeadquartersBollington, United Kingdom
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Adelphi Research does
Adelphi Research is a private UK-headquartered healthcare market research consultancy, founded around 1992 and operating as a subsidiary of Adelphi Group Ltd from offices in Bollington, Cheshire (UK) and Doylestown, Pennsylvania (US). The firm delivers bespoke strategic market research and consultancy services to global pharmaceutical, biotech, and healthcare organisations across the product lifecycle, with deep specialization in oncology, immunology, neurology, diabetes, and rare diseases. Its work has demonstrably influenced regulatory and policy outcomes, including contributing to UK NICE guidance on patient-preference study design and accepted amendments to the UK Mental Health Act.
The company's core offer is built around a portfolio of fourteen proprietary, trademarked methodologies (CAPMOD™, ECHO™, ASPIRE™, RAPIDA™, TRAXION™, PATHFINDER™, SIMCOM™, NUDGE™, PRISM™) and an underlying technology stack that includes a qualitative AI chatbot, an agile research platform, virtual-reality physician-patient simulation, a gamification suite, and an ILLUMINATE innovation lab. These combine behavioural science, advanced analytics, and AI to address specific pharma client pain points such as overstatement bias, brand white-space identification, message optimisation, and behavioural barriers to treatment.
Adelphi Research generates revenue through professional services engagements, with no public pricing disclosed. Engagements are custom, quote-based, and typically structured as multi-year contracts with enterprise pharmaceutical clients. Go-to-market is consultative and relationship-driven: senior leaders (President, Senior VP, Directors) directly engage clients, supported by conference presence, white papers, and thought leadership content. The firm serviced roughly 50 global pharmaceutical companies in 2023 and supported 155 brands across 461 studies in 2025.
Adelphi Research firmographics
Firmographics- Name
- Adelphi Research
- Legal name
- Adelphi Group Ltd
- Website
- https://adelphiresearch.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Adelphi Research is a UK-headquartered, privately-held healthcare market research consultancy serving global pharmaceutical companies with proprietary methodologies, behavioural science, AI, and agile research platforms across therapy areas including oncology, immunology, and diabetes.
- Ownership category
- akta.pro rank
Adelphi Research industry classification
Industry- Product category
- Healthcare Market Research Consultancy
- NAICS
- Marketing Research and Public Opinion Polling (54191), Marketing Consulting Services (541613)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Industry & Sector Research (Syndicated/Custom) (BPAHALAE)
- akta.pro secondary industries
- Product & Innovation Research (Concept, Pricing, Packaging, Conjoint) (MPAAALAI), Market Research, Analytics & Consumer Insights (BPAFAAAM)
Keywords
Where Adelphi Research is headquartered
LocationHeadquarters
- HQ city
- Bollington
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Adelphi Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Strategic Market Research Consultancy Services: Adelphi Research generates revenue through providing strategic market research and consultancy services to pharmaceutical and healthcare organisations. Services span the development lifecycle for new medicines and improved treatment approaches, including real-world disease understanding, value evidence, health economics, patient outcomes, market research, and medical communications. Engagements are custom, project-based consulting engagements typically serving enterprise pharmaceutical clients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based engagements tailored to pharmaceutical client requirements |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
Adelphi Research product offering
Product offeringCore offering
Adelphi Research is a global strategic market research consultancy that designs and delivers custom research engagements for pharmaceutical and healthcare organisations across the medicine development lifecycle. Its offerings span real-world disease understanding, patient preference and outcomes research, brand strategy and positioning, message testing, health economics and value evidence, congress insights, and medical communications support, drawing on proprietary methodologies (e.g., SIMCOM™, PRISM™, CAPMOD™), AI, behavioural science, gamification, and VR to produce bespoke insights for each client.
Product overview
Adelphi Research is a global healthcare market research consultancy offering a portfolio of proprietary methodologies and technology platforms. Their core intellectual property includes SIMCOM™ for message testing, CAPMOD™ for market prediction, ECHO™ for recall assessment, ASPIRE™ for positioning studies, RAPIDA™ for rapid quantitative-qualitative analysis, TRAXION™ for brand equity measurement, PATHFINDER™ for patient experience, and NUDGE™ for patient advocacy. These are complemented by technology platforms including AI Chatbot, Agile Solutions, Virtual Reality, and Gamification Suite. The company also operates Illuminate, an innovation lab, and applies PRISM™, a behavioural economics framework. Their approach combines advanced analytics, behavioural science, and AI to deliver insights for pharmaceutical and healthcare organisations.
Differentiator
Problem solved
Functional benefit
Products and services
- SIMCOM™ A branded proprietary message testing methodology that combines advanced analytics with interactive techniques such as TURF and MaxDiff to identify, optimise and deliver impactful pharmaceutical messaging across various engagement opportunities. Sold to enterprise pharmaceutical brand, marketing and medical affairs teams.
- PRISM™ A multidimensional proprietary framework applying behavioural, psychological and social science to business problems to elevate insights and uncover both articulated and unarticulated drivers of decision-making for pharmaceutical and healthcare clients.
- NUDGE™ A branded proprietary approach that uncovers psychological barriers preventing patients from taking action and drives them towards self-advocacy, supporting better healthcare outcomes for pharmaceutical clients.
- CAPMOD™ A branded proprietary methodology that addresses overstatement in research to avoid overestimation bias and produce more reliable market predictions for pharmaceutical clients.
- ECHO™ A branded proprietary gamified solution that accurately assesses respondent recall and identifies gaps in knowledge so pharmaceutical clients can focus messaging for greater impact.
- ASPIRE™ A branded proprietary methodology that identifies the white space a pharmaceutical brand can own by addressing the frustration with positioning studies that only test language rather than underlying ideas.
- RAPIDA™ A branded proprietary methodology that delivers combined quantitative assessment with real-time qualitative discussion when pharmaceutical clients need to make decisions quickly and accurately.
- TRAXION™ A branded proprietary sophisticated brand equity model and measurement of intrinsic brand associations through behavioural techniques for pharmaceutical clients.
- PATHFINDER™ A branded proprietary methodology that explores patient experience through multiple lenses, providing deep understanding of pain points, opportunities and their size to improve patient journeys for pharmaceutical clients.
- AI Chatbot Qualitative Research Solution A qualitative AI-powered chatbot that acts as a mediator between patient and physician, identifying underlying factors driving treatment selection and patient types by conversing with doctors in a naturalistic manner on behalf of pharmaceutical clients.
- Agile Solutions Platform A rapid research delivery platform leveraging AI to predict and optimise research objectives, focused on critical information needs and delivering results in weeks rather than months for pharmaceutical clients.
- Virtual Reality (VR) Research Environment Virtual Reality technology enabling understanding of how physicians position products to virtual patient avatars during treatment discussions, for use in pharmaceutical market research engagements.
- Gamification Suite A suite of gamified solutions designed to uncover cognitive biases and System 1 thinking, enhancing understanding of decision-making, priorities and associations in pharmaceutical respondents.
- Strategic Market Research Consultancy Engagements Custom, project-based strategic market research and consultancy services delivered to pharmaceutical and healthcare organisations across the medicine development lifecycle, including real-world disease understanding, value evidence, health economics, patient outcomes, market research, and medical communications support.
Quantifiable outcome
- Informed NICE guidance on patient preference study design for HTA submissions
- +3 more outcomes
Companies that use Adelphi Research
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles1 record
Adelphi Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature14 records
Adelphi Research partnerships and signals
Strategic signalScale indicators11 records
Expansion highlights6 records
Adelphi Research competitors and assessment
Company assessmentBroad incumbents
- ZS Associates: ZS Associates is a global management consulting firm with a large pharma commercial practice covering brand strategy, market research, and launch planning. Its oncology and specialty therapy insights work directly overlaps with Adelphi's engagements.
- IQVIA: IQVIA is the largest healthcare and life-sciences data, analytics, and consulting provider. While it spans clinical, RWD, and commercial services, its commercial insights and market research practice directly competes with Adelphi for pharma brand strategy and market understanding engagements.
- Clarivate (Decision Resources Group): Clarivate's DRG division delivers syndicated and custom market research, forecasting, and real-world insights to pharma and biotech. Competes with Adelphi for brand strategy, patient insights, and therapy-area research.
Direct peers
- BlueMatter Consulting: BlueMatter (part of EVERSANA) is a pharma strategy and insights consultancy focused on commercial strategy, patient insights, and market research. Comparable service offering and target client base to Adelphi Research.
- SKIM: SKIM is a healthcare and consumer market research firm specializing in pricing, message testing (conjoint, MaxDiff, TURF), and behavioural insights - overlapping directly with Adelphi's SIMCOM, TRAXION, and pricing-sensitive brand research work.
- Trinity Partners: Trinity Partners (now part of Inventiv Health / Concentrix) is a healthcare strategy consulting firm delivering strategic insights, market research, and commercial analytics to pharma. Comparable in mid-size custom engagement profile.
- Kantar Health: Kantar Health is a dedicated healthcare market research and insights consultancy serving global pharma and biotech clients with similar custom brand strategy, patient insights, and HCP research offerings - the closest direct competitor to Adelphi's core custom research model.
- Ipsos Healthcare: Ipsos Healthcare provides custom pharma market research, patient journey studies, and stakeholder insights across therapy areas. Operates globally with similar methodology-led, consultative delivery and competes for the same multinational pharma client budget as Adelphi.
- Cello Health (Apollo Intelligence): Cello Health, rebranded as Apollo Intelligence, is a healthcare-focused insights and analytics firm offering custom market research, brand strategy, and patient/HCP panels - directly comparable to Adelphi's mid-size custom research offering.
- Clarion (now part of Cencora): Clarion was a life-sciences commercial strategy and market research consultancy serving pharma clients with similar custom research, brand strategy, and patient/HCP insights offerings before its Cencora acquisition.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Adelphi Research social profiles
Digital presenceAdelphi Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Adelphi Research leadership team
Management profileNumber of profiles
Profiles4 records
Adelphi Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Adelphi Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Adelphi Research
What does Adelphi Research do?
Adelphi Research is a global strategic market research consultancy that designs and delivers custom research engagements for pharmaceutical and healthcare organisations across the medicine development lifecycle. Its offerings span real-world disease understanding, patient preference and outcomes research, brand strategy and positioning, message testing, health economics and value evidence, congress insights, and medical communications support, drawing on proprietary methodologies (e.g., SIMCOM™, PRISM™, CAPMOD™), AI, behavioural science, gamification, and VR to produce bespoke insights for each client.
Is Adelphi Research a public or private company?
Adelphi Research is a private company. It is classified as corporate owned and is currently operating.
When was Adelphi Research founded?
Adelphi Research was founded in 1992. It employs 101 to 250 people.
Where is Adelphi Research based?
Adelphi Research is headquartered in Bollington, United Kingdom, in the Europe region.
How does Adelphi Research make money?
One revenue line is on record: strategic Market Research Consultancy Services.
Who are Adelphi Research's main competitors?
Broad incumbents on record are ZS Associates, IQVIA and Clarivate (Decision Resources Group). Direct peers are BlueMatter Consulting, SKIM, Trinity Partners, Kantar Health, Ipsos Healthcare, Cello Health (Apollo Intelligence) and Clarion (now part of Cencora).
Does Adelphi Research have an API?
No public API is recorded for Adelphi Research.
What industry is Adelphi Research in?
Adelphi Research's product category is Healthcare Market Research Consultancy. Its primary akta.pro industry code is BPAHALAE, Industry & Sector Research (Syndicated/Custom), with a secondary code of MPAAALAI, Product & Innovation Research (Concept, Pricing, Packaging, Conjoint). Its NAICS code is 54191 and its SIC code is 8742.